Kurokawa T, Iinuma T, Ebisu H, Yanagidaira T, et al. A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and alpha-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol. PLoS One 2026;21:e0342387.
PMID: 41746943